E! 942, OxidoResist, HDxperts AB

49.51M kr SEK

Funder	Vinnova
Recipient Organization	Biomotif Ab
Country	Sweden
Start Date	Jul 01, 2022
End Date	Dec 15, 2025
Duration	1,263 days
Number of Grantees	2
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2022-00792_Vinnova`

Grant Description

Purpose and goal: ** Denna text är maskinöversatt ** The OxidoResist project aims to develop a technology to overcome drug resistance against cancer. OxidoResist technology will apply the innovative single-cell proteomics and modern AI-based bioinformatics to discover which FDA-approved drugs will

overcome resistance in combination with the anticancer drug under study. We will develop a universal pipeline for the discovery of optimal drug combinations that overcome resistance to target-specific therapies. Expected results and effects: ** Denna text är maskinöversatt ** The project aims to develop and introduce two new products on the market - 1) Medicines

against cancer with a new mechanism of action, 2) Service platform Approach and implementation: The OxidoResist project aims to develop a technology to overcome anticancer drug resistance. The OxidoResist technology will apply the innovative single cell proteomics and modern AI-based bioinformatics to discover which FDAapproved

drug(s) will overcome resistance in combination with the anti-cancer drug under study. We will develop a universal pipeline (joining top wet labs, AIbased bioinformatics, chemoinformatics, and network modeling) for the discovery of optimal drug combinations overcoming resistance to targetspecific therapeutics.